Aaron Lewis Durr

Title: The Innovative Contributions of Aaron Lewis Durr

Introduction

Aaron Lewis Durr is an accomplished inventor based in Glen Allen, VA (US). He has made significant contributions to the field of pharmaceuticals, particularly with his innovative approach to chewable tablet formulations. His work exemplifies the intersection of science and practical application in the healthcare industry.

Latest Patents

Durr holds a patent for a chewable tablet containing phenylephrine. This chewable pharmaceutical composition comprises phenylephrine, artificial sweetener, and a substantially aldehyde-free matrix. The formulation ensures phenylephrine stability suitable for a typical commercial product with a two-year shelf life. Additionally, the patent includes a method of manufacture and a method of use for the composition.

Career Highlights

Durr is associated with Wyeth, a prominent company in the pharmaceutical sector. His work at Wyeth has allowed him to focus on developing innovative solutions that enhance patient compliance and medication effectiveness. His dedication to improving pharmaceutical formulations has positioned him as a valuable asset in his field.

Collaborations

Durr has collaborated with notable colleagues, including Josephine Fubara and Mark Mabry. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical products.

Conclusion

Aaron Lewis Durr's contributions to the pharmaceutical industry through his innovative patent for a chewable tablet containing phenylephrine highlight his commitment to enhancing healthcare solutions. His work continues to impact the field positively.